Community Health Clinic, Inc. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 181 Columbia Ave, Vandergrift, PA 15690 Phone: 724-335-3334 Fax: 724-335-2283 |
Mohan M. Patel Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 224 Longfellow St, Suite 200, Vandergrift, PA 15690 Phone: 724-568-5551 Fax: 724-568-3137 |
Mohan M Patel Md Pc Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 235 Longfellow St, Vandergrift, PA 15690 Phone: 724-568-5551 Fax: 724-568-3137 |
Mohan Patel, Md Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 224 Longfellow St, Suite 200, Vandergrift, PA 15690 Phone: 724-568-5551 Fax: 724-568-3137 |
Community Health Clinic, Inc. Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 179 Columbia Avenue, Vandergrift, PA 15690 Phone: 724-335-3334 Fax: 724-335-2283 |
News Archive
Aging is a complex and natural process that affects all living organisms. As people age, normal biological processes are affecting, resulting in a decline in various organs and age-related conditions. Though aging is normal, some children affected by a disease called Progeria may age way faster than others.
Oxford Journals, a division of Oxford University Press, and the Infectious Diseases Society of America (IDSA), a leading professional society, have announced a new publishing partnership for IDSA's highly cited and internationally prestigious journals: Clinical Infectious Diseases (CID) and The Journal of Infectious Diseases (JID).
Head injury patients transferred to level I trauma centers are more likely to survive than if they're transferred to level II facilities, an Oregon Health & Science University study has found.
EntreMed, Inc., a clinical-stage pharmaceutical company developing therapeutics for the treatment of cancer, announced today that it has secured $10 million in financing with strategic accredited investors, including IDG-Accel China Growth Fund II L.P., Emerging Technology Partners, LLC, and Dr. Tak W. Mak, Director of The Campbell Family Institute for Cancer Research.
New data demonstrated that the combination asthma therapy, SYMBICORT (budesonide/formoterol fumarate dihydrate), led to significant improvements in health-related quality of life (HRQL) and greater patient-reported satisfaction with asthma treatment, versus its monocomponents (budesonide or formoterol) or placebo.
› Verified 3 days ago